SQ Innovation is a privately held Swiss biopharmaceutical company that focuses on developing innovative therapies for subcutaneous drug delivery, with the core goal of shifting treatment for conditions typically managed in hospital settings to a more convenient at-home setting. Its flagship product, Lasix® ONYU, was designed with careful consideration for patient comfort and needs, while simultaneously addressing practical factors important to healthcare providers, economic value, and environmental responsibility. Lasix ONYU received approval from the US FDA.